Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
TLX
vs
S
S&P/ASX 300
TLX
Over the past 12 months, TLX has outperformed S&P/ASX 300, delivering a return of +1% compared to S&P/ASX 300's 3% drop.
Stocks Performance
TLX vs S&P/ASX 300
Performance Gap
TLX vs S&P/ASX 300
Performance By Year
TLX vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Telix Pharmaceuticals Ltd
Glance View
Telix Pharmaceuticals is a biopharmaceutical company that develops and sells radiopharmaceuticals, which are medicines that use radioactive tracers to help doctors find or treat disease. Its best-known products are imaging agents used in cancer care, especially for prostate cancer, and it also develops therapies that target tumors more directly. The company makes money mainly by selling approved diagnostic products to hospitals, imaging centers, and specialist clinics, and by advancing newer drugs through clinical development and partnerships. In this business, the product is not a pill for long-term daily use; it is a targeted medicine that helps doctors see where disease is or deliver radiation to a tumor. Telix stands out because it sits at the intersection of drug development, nuclear medicine, and cancer diagnostics. That means it works with both pharmaceutical rules and hospital imaging workflows, and its value comes from turning radioactive compounds into practical tools that physicians can use in everyday cancer care.
